International Journal of Radiation Oncology Biology Physics
Dosimetric Comparison of Cesium-131 and Palladium-103 for Permanent Prostate Brachytherapy
Authors: J.S. Musmacher, R.T. Byrnes, M. Ghaly, K. Satchwill, L. Rumpf
Published: 01/11/2007
<a href="https://isoray.com/research-category/brachytherapy/">Brachytherapy</a>, <a href="https://isoray.com/research-category/brachytherapy/prostate/">Prostate</a>, <a href="https://isoray.com/research-category/results/treatment-planning/">Treatment Planning</a>

“Cesium provides everything we want for prostate brachytherapy as both a monotherapy and in combination therapy, including delivery of a high dose of radiation more quickly for high risk patients in a low dose rate ‘setting.’” 

Dr. Bernard W. Taylor, MD

Texas Oncology - Longview Cancer Center